![](/images/graphics-bg.png)
Hypertransfusion Therapy in Sickle Cell Disease in Nigeria
المؤلفون المشاركون
Adewoyin, Ademola Samson
Obieche, Jude Chike
المصدر
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-8، 8ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-08-07
دولة النشر
مصر
عدد الصفحات
8
التخصصات الرئيسية
الملخص EN
Introduction.
Hypertransfusion refers to chronic blood transfusion therapy aimed at ameliorating disease complications in various haemopathies particularly the haemoglobinopathies.
In sickle cell disease, hypertransfusion is aimed at maintaining patient’s haemoglobin level at 10 to 11 g/dL using haemoglobin AA blood and its resultant dilutional effect on sickle haemoglobin is sustained by intermittent long-term transfusions.
Aim and Objective.
This paper highlights hypertransfusion and its privileged position as a secondary measure in prevention and treatment of sickle cell disease, especially in the Nigerian context.
Materials and Methods.
Relevant literatures were searched on PubMed, Google Scholar and standard texts in haematology and transfusion medicine.
Keywords used in the search are hypertransfusion, sickle cell disease, chronic transfusion, and Nigeria.
Literatures gathered were reviewed, summarized, and presented in this paper.
Result.
Immense clinical benefit is associated with hypertransfusion therapy including prevention of stroke and amelioration of severe sickle cell disease especially in transplant ineligible patients.
Careful patient selections, appropriate blood component, and prevention of transfusion hazards as well as oversight function of an experienced haematologist are pertinent to a successful hypertransfusion therapy.
Conclusion.
Improved knowledge of the benefits and practice of hypertransfusion will effectively translate into improved health status even among Nigerian sickle cell disease patients.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Adewoyin, Ademola Samson& Obieche, Jude Chike. 2014. Hypertransfusion Therapy in Sickle Cell Disease in Nigeria. Advances in Hematology،Vol. 2014, no. 2014, pp.1-8.
https://search.emarefa.net/detail/BIM-508414
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Adewoyin, Ademola Samson& Obieche, Jude Chike. Hypertransfusion Therapy in Sickle Cell Disease in Nigeria. Advances in Hematology No. 2014 (2014), pp.1-8.
https://search.emarefa.net/detail/BIM-508414
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Adewoyin, Ademola Samson& Obieche, Jude Chike. Hypertransfusion Therapy in Sickle Cell Disease in Nigeria. Advances in Hematology. 2014. Vol. 2014, no. 2014, pp.1-8.
https://search.emarefa.net/detail/BIM-508414
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-508414
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)